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School of Medicine, Tel Aviv University, Tel Aviv, IsraelABSTRACT The glucocorticoid receptor (GR) is a steroid-hormone-activated transcription factor that modulates gene expres-
sion. Transcriptional regulation by the GR requires dynamic receptor binding to specific target sites located across the genome.
This binding remodels the chromatin structure to allow interaction with other transcription factors. Thus, chromatin remodeling is
an essential component of GR-mediated transcriptional regulation, and understanding the interactions between these molecules
at the structural level provides insights into the mechanisms of how GR and chromatin remodeling cooperate to regulate gene
expression. This study suggests models for the assembly of the SWI/SNF-A (SWItch/Sucrose-NonFermentable) complex
and its interaction with the GR. We used the PRISM algorithm (PRotein Interactions by Structural Matching) to predict the
three-dimensional complex structures of the target proteins. The structural models indicate that BAF57 and/or BAF250 mediate
the interaction between the GR and the SWI/SNF-A complex, corroborating experimental data. They further suggest that a
BAF60a/BAF155 and/or BAF60a/BAF170 interaction is critical for association between the core and variant subunits. Further,
we model the interaction between GR and CCAAT-enhancer-binding proteins (C/EBPs), since the GR can regulate gene
expression indirectly by interacting with other transcription factors like C/EBPs. We observe that GR can bind to bZip domains
of the C/EBPa homodimer as both a monomer and dimer of the DNA-binding domain. In silico mutagenesis of the predicted
interface residues confirm the importance of these residues in binding. In vivo analysis of the computationally suggested muta-
tions reveals that double mutations of the leucine residues (L317DþL335D) may disrupt the interaction between GR and
C/EBPa. Determination of the complex structures of the GR is of fundamental relevance to understanding its interactions
and functions, since the function of a protein or a complex is dictated by its structure. In addition, it may help us estimate the
effects of mutations on GR interactions and signaling.INTRODUCTIONThe glucocorticoid receptor (GR) is a member of the nuclear
receptor superfamily of transcription factors, which play
critical roles in a variety of biological processes, including
homeostasis and metabolism. It consists of a hypervariable
N-terminal domain, a DNA-binding domain (DBD), a hinge
region, and a ligand-binding domain (LBD) (1). GR carries
two transcriptional activation functions (AFs), one in the
N-terminal domain and the other within the LBD, for the
transactivation of gene expression (2). Upon ligand binding,
GR translocates from the cytoplasm to the nucleus, where it
homodimerizes and produces transcriptional activation or
repression, often by direct high-affinity binding to glucocor-
ticoid-responsive elements (GREs) in DNA. However, not
all glucocorticoid-modulated genes contain a DNA-bindingSubmitted March 3, 2015, and accepted for publication June 23, 2015.
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0006-3495/15/09/1227/13site for GR. Thus, GR interacts with other transcription fac-
tors such as CCAAT-enhancer-binding proteins (C/EBPs),
NF-kB, and AP-1 to alter their function and mediate the
responses to glucocorticoids (3).
Eukaryotic genes are highly organized into a multilayered
chromatin architecture that has a repressive effect on
gene transcription by inhibiting access of regulatory factors
to recognition sequences within target promoters (4–6).
Thus, modulation of chromatin structure by ATP-dependent
chromatin-remodeling complexes plays a fundamental role
in gene expression.GRmakes direct interactionswith several
subunits of chromatin-remodeling complexes upon confor-
mational change induced by hormone binding (7). Chro-
matin-remodeling complexes manipulate the nucleosome
architecture to allow binding of transcription factors to chro-
matin (8–10). Cells contain multiple distinct chromatin-re-
modeling complexes, including SWI/SNF (SWItch/
Sucrose-NonFermentable) (11). All SWI/SNF complexes
include an SWI2/SNF2-type ATPase, which uses the energyhttp://dx.doi.org/10.1016/j.bpj.2015.06.044
1228 Muratcioglu et al.from ATP hydrolysis to alter the structures of nucleosomes
(5,12). The SWI/SNF family of chromatin remodelers
has been very well studied, especially in the prototype
yeast model (13–15). Unlike the yeast SWI/SNF complex,
mammalian SWI/SNF is composed of a heterogeneous
mixture of subunits that contain BRG1 or BRM ATPase in
addition to BRG1-associated factors (BAFs). Human SWI/
SNF contains 10–12 BAFs. Although some BAF proteins
(BAF155, BAF57, BAF47, and BAF53) are present in all
SWI/SNF complexes, others are interchangeable. Human
SWI/SNF can be further grouped into two subfamilies,
BAF (BRG1- or HRBM-associated factor, also called SWI/
SNF-A) and PBAF (polybromo-associated BAF, also called
SWI/SNF-B). Though members of these subfamilies include
common subunits, their subunit composition is not entirely
the same: BAF250 is only associated with the BAF complex,
whereas BAF200 and BAF180 are exclusively present in the
PBAF complex (16–18).
The SWI/SNF chromatin remodeling complex has been
implicated in glucocorticoid-stimulated transcription by in-
teracting with GR (19). Binding of the receptor to GREs
leads to recruitment of the BRG1-associated remodeling
complex and results in changes in gene expression. Multiple
interactions between GR and BAF subunits are involved in
recruitment and stabilization of the SWI/SNF remodeling
complex at target promoters. In vitro assays have previously
demonstrated that GR lacking the LBD can interact with
BAF60a and BAF57, but not with the core components
BRG1, BAF170, or BAF155 (20). Nie et al. (17) showed
that BAF250 enhances GR-mediated transcriptional acti-
vation by about sixfold. Pull-down experiments suggest a
direct interaction between GR and the BAF250 C-terminal
region. These results suggest that BAF250 and/or BAF60a
of SWI/SNF mediate the interaction between GR and
BRG1 (20). By utilizing protein-protein interactions to
recruit remodelers to binding sites, agonist-activated GR
produces chromatin remodeling, allowing neighboring tran-
scription factor binding sites to be accessed by their relevant
proteins in addition to GR (21).
CCAAT-enhancer-binding proteins a and b (C/EBPa and
C/EBPb), belonging to the C/EBP family of transcription
factors, have also been shown to recruit the SWI/SNF
complex to target promoters. C/EBP proteins regulate the
differentiation of several cell types, such as adipocytes,
neutrophil granulocytes, eosinophils, and hepatocytes
(22–24). They are composed of six members (C/EBPa–
C/EBPz). These proteins share ~90% sequence identity in
the C-terminal 55–65 amino acid residues, which contains
the basic-leucine zipper (bZIP) domain. This domain is
responsible for dimerization and DNA binding (25). In
contrast to the highly conserved C-termini, the N-terminal
domains of C/EBP proteins are widely divergent, except
for three short subregions. These subregions represent the
activation domains involved in transcriptional activation
(TADs) (26), and involvement in chromatin remodelingBiophysical Journal 109(6) 1227–1239has been demonstrated. For example, biochemical and im-
munoaffinity experiments showed that the C/EBPb TAD in-
teracts directly with the hBrm/BRG1 central ATPase (27),
and the C/EBPa transactivation element III (TE-III) has
been shown to interact with Brm ATPase and the BAF155
core SWI/SNF subunit (28).
Functional genomics experiments in intact liver tissue
and differentiating 3T3-L1 preadipocytes have demon-
strated cooperative interplay between GR and C/EBPb at
the level of chromatin accessibility (29–31). Depending
on the genetic composition and chromatin configuration of
the binding site, GR can assist loading of C/EBPb or
C/EBPb can assist loading of GR (29). Yet direct protein-
protein interaction (known as tethering) can also be utilized
to deliver both factors to the genome even when a DNA
binding site is only present for one (32,33). Thus, GR and
C/EBP access to chromatin is regulated by a) the ability to
recruit chromatin remodelers, leading to modulation of the
local chromatin environment, and/or b) direct interaction
between the transcription factors.
Here, we suggest models of how SWI/SNF-A subunits
interact structurally with one another and with GR to induce
chromatin remodeling and facilitate GR-mediated transcrip-
tion, respectively. We used the PRISM (34,35) algorithm
(PRotein Interactions by Structural Matching) to predict
the binary interactions between these molecules. There are
different computational methods for the prediction of pro-
tein and domain interactions (36). One approach involves
using the sequence data of the query proteins and assessing
the likelihood of the interaction based on the identification
of structural features by sequence similarity (37). More
than half of the methods, however, incorporate evolutionary
information (38,39) and/or protein structure to improve the
accuracy of the predictions (40). PRISM is a powerful tem-
plate-based protein-protein complex-structure-prediction
algorithm that utilizes the structural similarity between tem-
plate interfaces and target surfaces. In a recent study, Vreven
et al. (41) compared the performance of template-based
(including PRISM) and template-free (ZDOCK) protein-
protein interaction-prediction methods. According to their
results, the template-based methods show similar perfor-
mance to ZDOCK and in fact are more successful in cases
where the proteins undergo conformational changes upon
binding.
Exploiting PRISM, we built models for the core and
variant BAF units based on the predicted binary interactions
and determined the complex structures of the subunits
capable of interacting directly with the GR. In addition,
we model the interaction between GR and C/EBP to
describe how these transcription factors can facilitate each
other’s recruitment to DNA through tethering. We tested
the GR-C/EBP models by in silico mutation of the pre-
dicted interface residues, observing an elimination of the
predicted GR-C/EBP interaction and supporting the signifi-
cance of these residues for the complex formation. Identical
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to further validating the structural predictions. The pro-
posed models for GR-SWI/SNF and GR-C/EBP interactions
conceptually illustrate two of the many arrangements by
which GR may modify transcriptional responses in associa-
tion with other proteins.MATERIALS AND METHODS
Computational prediction of the structures of GR
with SWI/SNF components and C/EBP
In this study, we used PRISM (34,35) to model the interactions between GR
and the SWI/SNF chromatin-remodeling complex and between GR and
C/EBPs. PRISM predicts the structures of protein complexes by utilizing
the structural similarity between template experimental interfaces and
target surfaces, and it generates a couple of putative models for the query
interaction using these template interfaces. In the last step, rigid docking
solutions are flexibly refined to resolve steric clashes and ranked according
to their global energy. The one with the lowest binding energy score (BES)
is considered to be the best solution. In this way, geometric complemen-
tarity is incorporated into the docking procedure. When PRISM yields
more than one putative model, we first search the literature to see whether
there are any experimental findings that corroborate our models; if not, we
choose the one with the lowest BES.
Structural data for GR and C/EBP proteins were obtained from the
Protein Data Bank (PDB). We used both the DBD and the LBD of GR
as our targets. We obtained model structures of SWI/SNF subunits using
I-TASSER (42), since there were no available structures in the PDB.
We chose the models that have a percentage sequence identity of the tem-
plates in the aligned region with the query sequence >30%. The sequence
alignments and the threading results of the modeled structures are shown
in Fig. S1 and Table S1, respectively, in the Supporting Material. Table 1
lists the proteins used in the predictions. Predictions were made using the
BRG1 complex and core BAF units (BAF155, BAF47, and BAF170) and
BAF250, BAF57, and BAF60a in addition to the BRG1 ATPase as our
target proteins. We predicted the complex structure of GR with C/EBP
using the DBD and bZip domain, respectively, then identified the contact
regions using HotRegion (43). HotRegion is a database of predicted hot-
spot clusters. Using predicted hot-spot residues that are major contributors
to the binding energy, it identifies the regions that are important for the
stability of protein complexes. We built putative models for the multipro-
tein complexes based on predicted binary interactions and available liter-
ature data. We performed a detailed analysis of interfaces to investigate
the stability of the predicted complexes using the tool Protein Interfaces,TABLE 1 List of proteins used in PRISM predictions
PDB Structures Model Structures
Protein Domain/Region PDB ID Protein Domain/Region
GR DBD 1GLU, 3G9M BAF155 SWIRM and
coiled-coil
GR LBD 1P93, 3E7C BAF170 SWIRM and
coiled-coil
C/EBPa bZip 1NWQ BAF60a C-terminal
(residues between
140 and 435)
BRG1 bromodomain 2GRC BAF250 C-terminal
(residues between
1640 and 2250)
BAF47 full length
BAF57 full lengthSurfaces, and Assemblies (PDBePISA) (44). We used the default param-
eters for calculations. PDBePISA provides information about the total sol-
vent-accessible surface area, and about the interface area, which is the
difference between the total accessible surface areas of monomeric and
complex structures divided by two. It also calculates the number of poten-
tial hydrogen bonds and salt bridges across the interface. Finally, we used
EPPIC Server (45) and NOXclass (46) to distinguish biologically relevant
interactions from nonbiological interactions resulting from crystal-packing
contacts. EPPIC uses the number of core residues and two evolutionary
indicators based on the sequence entropy of homolog sequences to deter-
mine the biological character of interfaces. It uses the following cutoff
values: six core residues for geometry, 0.75 for the entropy core/rim
ratio, and 1.0 for core-versus-surface scores. NOXclass utilizes interface
properties such as interface area, interface area ratio, and area-based
amino acid composition of the protein-protein interface to determine
whether an interaction is biological or crystal packing. It uses the
following cut-off values: 650 A2 for the interface area and 0.07 for the
interface-area ratio.In silico construction of C/EBP mutants
To confirm the residues predicted as structurally important for complex
formation between GR and C/EBPs, Leu residues at positions 315, 317,
335, and 341 were mutated in silico. We first mutated these residues to
Asp and performed energy minimization using the FoldX computational
algorithm (47,48). Then, we used PRISM to predict the effects of mutations
on GR-C/EBP interactions.Cell culture and reagents
Dexamethasone (Dex) was purchased from Sigma-Aldrich (St. Louis, MO).
Cells from the 3617 mouse mammary adenocarcinoma cell line were
routinely cultured in Dulbecco’s modified Eagle’s medium high glucose
supplemented with 10% fetal bovine serum (Hyclone, South Logan, UT)
and 1% L-glutamine (Life Technologies, Grand Island, NY). The 3617
cell line contains a large tandem array (~200 copies) of a mouse mammary
tumor virus, Harvey viral ras (MMTV-v-Ha-ras) reporter integrated into
chromosome 4 (49). At all times, 3617 cells were grown in the presence
of 5 mg/mL tetracycline (Sigma-Aldrich) to prevent expression of a stably
integrated GFP-GR (49,50). Before glucocorticoid treatments, cells were
seeded to two-well Lab-Tek chamber slides (Thermo Fisher, Waltham,
MA) and incubated for at least 18 h in Dulbecco’s modified Eagle’s medium
containing 10% charcoal-stripped fetal bovine serum (Hyclone) and 1%
L-glutamine.Plasmids and transient transfection
mCherryFP-GR and mCherry-NF-1 were described previously (50,51).
mCherryFP-GR contained rat GR with a C656G change separated from
mCherry fluorescent protein by the linker 50-YKSGLRSRGAGAGA
GAGA-30. pEGFP-C/EBPa (a kind gift from Fred Schaufele, University
of California San Francisco, San Francisco, CA) contained rat C/EBPa
tagged on the N-terminal with a L65F and L232H variant of the
enhanced green-fluorescent protein (EGFP). A 16-amino-acid linker,
50-QASTMDYKDDDDKDYA-30, bridges EGFP and C/EBP. C/EBP
mutations were generated using a QuikChange II XL site-directed muta-
genesis kit according to the manufacturer’s instructions (Stratagene, La
Jolla, CA). Mutagenesis primers were designed through http://www.
genomics.agilent.com/primerDesignProgram.jsp, and new plasmids
were sequenced across the entire protein coding region to verify the
desired mutations. Transient transfection of 3617 cells was performed
with jetPRIME reagent (PolyPlus, New York, NY) according to the man-
ufacturer’s instructions.Biophysical Journal 109(6) 1227–1239
1230 Muratcioglu et al.Subcellular localization and N&B analysis
The 3617 cells were transiently transfected with 1 mg of pEGFP-CEBPa or
its mutant variants, combined with 1 mg mCherryGR or mCherry-NF-1 as
indicated. Cells were incubated for at least 20 min with 100 nM Dex and
imaged at the CCR Confocal Microscopy Core Facility (NIH, Bethesda,
MD) on a LSM 780 laser scanning microscope (Carl Zeiss, Inc., Thorn-
wood, NY) fitted with a 63X oil immersion objective (NA¼1.4). The exci-
tation source was a multi-line Ar laser tuned at 488 nm and/or a 594 nm
laser. Fluorescence was detected with a GaAsP detector in photon-counting
mode. Number and brightness (N&B) measurements were performed as
previously described (52).RESULTS
Prediction of GR complex structures with SWI/
SNF components
GR has been shown experimentally to interact with
BAF60a and BAF57 through its DBD domain and with
BAF250 through its LBD domain, suggesting that in vivo,
GR has at least three BAF proteins with which to associate
(Fig. 1) (17,20). Here, we focused on these interactions and
modeled the complex structures using PRISM. Our results
confirmed that GR DBD can bind with high affinity to
BAF57 (Fig. 2 A). The BES for the prediction is 57.67.
On the basis of our previous studies (34,53–55), we set
the energy-score cutoff value as 10. Thus, predictions
with BES values <10 are considered to be favorable in-
teractions. Pull-down assays previously demonstrated that
GR interacts strongly with the N-terminus of BAF60a,
but not with the C-terminus. We generated structural
models of the BAF60a N-terminal (residues between 4
and 140) and C-terminal regions (residues between 140
and 435). Unlike the C-terminal region, modeling of the
BAF60a N-terminal did not yield good-quality models.
The sequence identity between our protein and the tem-
plate for the model was <30% (Table S2 and Fig. S3),
so we did not use it in our predictions. Consequently, we
were not able to see whether BAF60a can interact with
GR DBD through its N-terminus. Instead, using PRISM,
we tested whether BAF60a can interact with GR DBD
through its C-terminal region, but we did not observe anBiophysical Journal 109(6) 1227–1239interaction between these two proteins, supporting the
experimental results. Deletion experiments demonstrated
that the C-terminal region of BAF250 can directly bind
to GR (17). We generated a model structure of the
BAF250 C-terminal region (residues between 1641 and
2250) and predicted putative models for the GR-BAF250
interaction. Our results demonstrated that GR can form
stable complexes with BAF250 through its LBD, but not
through its DBD (Fig. 2 B). The BES for the prediction is
24.01. The predicted interface involves residues between
2149 and 2164, close to the C-terminus of BAF250,
corroborating the experimental results. Table 2 illustrates
the results of a detailed interface analysis of both predic-
tions (GR DBD/BAF57 and GR LBD/BAF250). We also
tested whether these suggested interfaces (Fig. 2) are
considered to be biological interactions or crystal-packing
contacts. Both interactions are classified as biological ac-
cording to EPPIC and NOXclass. Interface features calcu-
lated by EPPIC and NOXclass are tabulated in Tables S3
and S4 and Fig. S4.Prediction of complex structures of core BAF
units
SWI/SNF core subunits include BAF155, BAF170, and
BAF47 in addition to the BRG1 catalytic ATPase. The struc-
ture of this multiprotein complex was constructed by super-
imposing the predicted binary interactions between BAF155
and BRG1, BRG1 and BAF47, and BAF47 and BAF170
(Fig. 3 A).
The BAF155 and BAF170 proteins are highly homolo-
gous and likely exist either as heterodimers (BAF155/
BAF170) or as homodimers (BAF155/155 or BAF170/
170) through a leucine zipper motif in the cell (56).
Fig. 3 B shows the predicted coiled-coil heterodimer struc-
ture (BAF155/BAF170). Our modeling results indicate that
the BAF155/BAF170 heterodimer can interact with BRG1
through the BAF155 coiled-coil region (Fig. 3 C). However,
neither BAF155 nor BAF170 can bind BAF47 through their
coiled-coil regions. Thus, the BAF170 SWIRM domainFIGURE 1 The interaction of GR with the com-
ponents of the SWI/SNF-A (BAF) complex. SWI/
SNF complexes consist of a single ATPase (BRM
or BRG1, red), evolutionarily conserved core pro-
teins (BAF155, BAF170, and BAF47, purple), and
variant subunits (BAF60a, b, or c; BAF57; BAF53a
or b; BAF250a or b; and b-actin, green). Pull-down
experiments indicate that there are at least three
proteins in the BAF complex that can associate
with GR (orange). The dashed lines represent the
hinge region (40 residues long) between the DBD
and LBD of GR. BAF250 binds to the GR LBD,
and BAF57 and BAF60 bind to the GR DBD. To
see this figure in color, go online.
FIGURE 2 Predicted complex structures of GR
with SWI/SNF components. (A) Predicted com-
plex structure of DNA-bound GR DBD (PDB ID
1glu, pink) with the SWI/SNF-related matrix-asso-
ciated actin-dependent regulator of chromatin sub-
family E member 1 (SMARCE1/BAF57) (model,
lilac). The BES for the prediction is 57.67 (tem-
plate interface 3usuGH). The interface residues of
GR are M434, K435, P439, L441, V442, C443,
S444, R479, N480, I483, I484, D485, R488,
R498, K499, Q502, A503, G504, and R510. The
interface residues of BAF57 are D184, G185,
F186, S187, H190, Q232, V236, H237, L241,
E242, L246, E249, E250, H252, Q253, K256,
Q295, K298, R299, and E302. N and C represent
the N- and C-termini, respectively, of the modeled
regions. (B) Predicted complex structure of the GR
LBD (PDB ID 1p93, pink) with AT-rich interactive-domain-containing protein 1A (ARID1A/BAF250) (model, green). The BES for the prediction is24.01
(template interface, 3zrjAB). The interface residues of the GR are D641, H726, E727, E730, N731, L732, N734, Y735, F737, Q738, K771, and L773. The
interface residues of BAF250 are S509, R513, D517, N520, P521, V522, C523, and R524. N and C represent the N- and C-termini, respectively, of the
modeled regions. To see this figure in color, go online.
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BAF47 and the other core subunits.The structural interaction of core BAF units with
variant subunits
Pull-down assays with BRG1, BAF170, BAF155, BAF57,
and BAF60a performed previously showed direct interac-
tions between the C-terminus of BAF60a and BAF170 and
BAF155 and no interactions between BAF60a and BAF57
(20). Our modeling results indicated that variant subunit
BAF60a can form stable complexes through its C-terminal
domain with the BAF155 or BAF170 SWIRM domain in
the core; supporting existing experimental findings (20)
(Fig. 4, A and B). The C-terminal domains of BAF60a
and BAF57 were not predicted by PRISM to interact. To
test whether BAF60a can interact with BAF155 and/or
BAF170 in the presence of other core subunits, we superim-
posed the predicted binary interactions onto our core model
(Fig. 4, C and D). No clashes were observed from our
protein models. Predictions suggest that BAF60a can also
interact with the BAF170 coiled-coil region (Fig. 5 A).TABLE 2 Interface analysis of GR DBD/BAF57 and GR LBD/BAF25
No. of Residues (Nres)
Surface Area (A˚2)Interface (%) Total (%)
GR DBD/BAF57 Complex (BES 57.67)
GR DBD 20 (24.7) 81 (100) 5929
BAF57 21 (5.1) 411 (100) 30,384
Complex
GR LBD/BAF250 Complex (BES 24.01)
GR LBD 12 (2.4) 492 (100) 37,299
BAF250 8 (1.3) 610 (100) 24887
Complex
The number of interface residues for both monomers and complexes are shownUsing these binary interactions, we constructed the structure
of the complex composed of the BAF155/BAF170 het-
erodimer, BRG1, and BAF60a (Fig. 5 B). Taken together,
we present two possible ways for the core-variant subunit
to interact: BAF155/BAF170 proteins can use their SWIRM
domains to interact with both core and variant subunits or
mediate the interaction between core and variant subunits
using both SWIRM domains and coiled-coil regions.
We further predicted the interactions betweenBAF60a and
other variant subunits. Our results indicate that BAF60a can
interactwithBAF250 (Fig. 6A) through an interface different
from the BAF155/BAF170 binding site. Fig. 5 B shows the
multiprotein complex between BAF250, BAF60a, and
BAF57. BAF250 has been shown to interact with the heli-
case-SANT-associated domain of BRG1 (57). Predictions
confirm this interaction and further suggest that BAF250
can bind to both BRG1 and the GR LBD (not shown). Taken
together, our results suggest that variant subunits BAF60a
and BAF250 may coordinate with the core SWI/SNF com-
plex via multiple core subunits, including BAF155/
BAF170, BAF57, and BRG1. To test whether GR, BAF57,
and BAF250 can form a ternary complex, we superimposed0 complexes
Interface Area (A˚2)
No. of Hydrogen
Bonds (NHB)
No. of Salt
Bridges (NSB)
1176.3 11 10
691.4 1 3
together with their percentage.
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FIGURE 3 Predicted complex structures of core
SWI/SNF components. (A) Core BAF subunits
include the SWIRM domain of SWI/SNF complex
subunit SMARCC1 (BAF155) (model, light blue);
the bromodomain of transcription activator BRG1
(SMARCA4) (PDB ID 2grc, magenta); the SWI/
SNF-related matrix-associated actin-dependent
regulator of chromatin subfamily B member 1
(SMARCB1/BAF47) (model, green), and the
SWIRM domain of SWI/SNF complex subunit
SMARCC2 (BAF170) (model, violet). The structure
of the core complex is built via superimposition of
the predicted binary interactions between BAF155
and BRG1 (BES 13.15; template interface,
3sn6AR),BRG1andBAF47 (BES10.81; template
interface, 3krtAC), and BAF47 and BAF170 (BES
10.02; template interface, 1q85AB). N and C
represent the N- and C-termini, respectively, of the
modeled regions. (B) Coiled-coil heterodimer of
BAF155 (model, light blue) with BAF170 (model,
violet). The BES for the prediction is 28.99 (tem-
plate interface, 2ieqAC). N and C represent the
N- and C-termini, respectively, of the modeled
regions. (C) Predicted complex structure of the
BAF155/BAF170 heterodimer with BRG1. The
BES for the prediction is12.61 (template interface,
1ylmAB). To see this figure in color, go online.
1232 Muratcioglu et al.the BAF57/GR and BAF57/BAF250 interactions (Fig. 6 C).
The model suggests that the two interactions can co-occur
and that BAF57 can interact with GR and BAF250
simultaneously.Prediction of GR complex structures with C/EBP
Experimental studies suggest a complex formation between
the DBD of GR and the bZip domain of C/EBPa that can
bind DNA (32). Using PRISM, we predicted putativeBiophysical Journal 109(6) 1227–1239models for this interaction. Our models suggest that both
monomeric and dimeric GR can bind to a C/EBPa homo-
dimer through the GR DBD domain (Fig. 7). The binding
sites are positioned in the region close to the dimerization
interface of C/EBPa. Table 3 illustrates the results of a
detailed interface analysis of both predictions (GR DBD/
CEBP models). To further validate our models, we per-
formed in silico mutations for the predicted interface
residues and compared the binding affinities of the wild-
type and mutant C/EBPs in terms of BES values. Table 4FIGURE 4 Predicted complex structures of core
BAF units with the BAF60a variant subunit. (A)
Predicted complex structure of the SWI/SNF-
related matrix-associated actin-dependent regu-
lator of chromatin subfamily D member 1
(SMARCD1/BAF60a) (model, blue) with core
subunit BAF155 (light blue) (BES 49.56; tem-
plate interface, 3ephAB). The modeled structure
of BAF60a represents only the region close to the
C-terminal domain, so N and C represent the N-
and C-termini, respectively, of the BAF60a C-ter-
minus. (B) Predicted complex structure of
BAF60a (model, blue) with core subunit BAF170
(BES 45.45; template interface, 3ephAB). (C
and D) BAF60a is predicted to join the SWI/SNF
core complex through interactions with BAF155
(C) and/or BAF170 (D). To see this figure in color,
go online.
FIGURE 5 Predicted complex structures of core
BAF units with BAF60a variant subunit. (A) Pre-
dicted complex structure of BAF60a (model,
blue) with the BAF170 coiled-coil region (model,
violet) of the BAF155/BAF170 heterodimer (BES
33.31; template interface, 3griAB). N and C
represent the N- and C-termini, respectively, of
the modeled regions. (B) The structure of the com-
plex is built via superimposition of the predicted
binary interactions between the BAF155/BAF170
heterodimer and BRG1, and BAF170 and
BAF60a. N and C represent the N- and C-termini,
respectively, of the modeled regions. To see this
figure in color, go online.
Modeling of GR with SWI/SNF and C/EBP 1233summarizes the effects of different mutations on C/EBP
dimerization and GR-C/EBP interaction. Although the
mutations weakened C/EBP dimerization, they did not
completely disrupt it. On the other hand, some C/EBP mu-
tants were predicted in silico to not bind GR. The results
indicate that L315D and L317D mutations have more pro-
found effects than L335D, since these mutations disrupted
the interaction rather than weakening it as L335D did. As
expected, I341D had no effect on either interaction; it did
not change the BES significantly, since I341 is not located
at the interface (Fig. 8). Overall, the results suggested that
these mutations affect GR-C/EBP association, verifying
the predicted interface residues for binding.In vivo testing of GR-C/EBP interactions
In silico analysis predicted that C/EBPa could interact with
either the monomeric or the dimeric form of the GR (Fig. 7).
To test which type of complexes form in vivo, we performedN&B analysis in living cells expressing fluorescently tagged
GR and C/EBPa. This technique, based on moment anal-
ysis, provides the average number of moving fluorescent
molecules and their brightness at every pixel in the images.
With this information, the relative oligomerization state of a
protein can be determined (58). Using this approach, it was
shown previously that activated GR is mostly dimeric inside
the nucleus (52,59). Thus, if C/EBP were to interact with
GR as a monomer, we would expect a decrease in the
dimeric population of GR when C/EBPa is coexpressed.
On the other hand, if the GR-C/EBP complex contains GR
dimers, then the GR population will remain dimeric
independently of the presence of C/EBP. N&B analysis
(Fig. 9 A) shows that GR nuclear brightness in the presence
of C/EBP remains consistent with a fully dimeric receptor,
suggesting that GR interacts with C/EBP as a dimer.
Our in silico studies further predict that specific residues
in C/EBP are involved in the GR-C/EBP interface and that
mutation of these residues would disrupt GR-C/EBPFIGURE 6 Predicted complex structures be-
tween variant SWI/SNF subunits. (A) Predicted
binary interaction of BAF250 (model, green)
with BAF60a (model, blue). The BES for the pre-
diction is 25.91 (template interface, 3s28BC).
(B) Predicted complex structure between BAF250
(green), BAF60a (blue), and BAF57 (lilac). The
structure of the complex is built via superimposi-
tion of the predicted binary interactions between
BAF250 and BAF60a, and BAF57 and BAF250.
(C) The structure of the complex is built via super-
imposition of the predicted binary interactions
between GR and BAF57, and BAF57 and
BAF250 (BES 27.56; template interface,
1jm0BE). To see this figure in color, go online.
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FIGURE 7 Predicted complex structures of GR with C/EBP. (A) First
model for the complex structure between the GR DBD (PDB ID 3g9m,
pink) and C/EBPa (PDB ID 1nwq, blue). The BES for the prediction is
16.64 (template interface, 3zylAB). The interface residues of GR are
H438, M439, L441, V442, C443, S444, A447, L455, R479, N480, D481,
D485, R498, K499, Q502, and A503. The interface residues of C/EBP
are Q312, L315, E316, L317, S319, D320, N321, R323, L324, K326,
R327, V328, Q330, L331, S332, E334, and L335. N and C represent the
N- and C-termini, respectively, of the modeled regions. (B) Second model
for the complex structure between the GR DBD (PDB ID 1glu, pink) and
C/EBPa (PDB ID 1nwq, blue). The BES for the prediction is 27.16 (tem-
plate interface, 1s7oBC). Although GR is a dimer of DBDs, only one mono-
mer interacts with dimeric C/EBPa. The interface residues of GR are
M434, K435, E446, G458, S459, V462, F463, R466, N473, Y474, L475,
K490, and P493. The interface residues of C/EBP are A295, V296,
K298, S299, R306, Q311, Q312, K313, L315, E316, L317, S319, D322,
and K326. N and C represent the N- and C-termini, respectively, of the
modeled regions. To see this figure in color, go online.
1234 Muratcioglu et al.complex formation (Table 4). To test this hypothesis in vivo,
we analyzed the recruitment of C/EBP at a specific GR-
DNA-binding locus inside living cells. The amplified array
of a GR responsive promoter structure (the MMTV array)
in 3617 cells contains 800–1200 GR binding sites (60)
and DNA recognition sequences for the nuclear factor-1
(NF-1) protein (50). Thus, fluorescently tagged proteins
binding to this region (e.g., GR or NF-1) can be directly
visualized in living cells as a bright spot in the nucleoplasm.
If GR interacts with C/EBP, then C/EBP should be recruited
to the array in a manner dependent on GR activation by
glucocorticoids.
First, we ruled out the possibility that C/EBP was able to
bind the array in a glucocorticoid-independent manner.
C/EBP is constitutively nuclear and presents a nonhomoge-
nous intranuclear distribution, forming aggregates in hetero-
chromatin regions (61) (Fig. 9 B). As visual discrimination
between the MMTV array and heterochromatin regionsBiophysical Journal 109(6) 1227–1239was not possible by examining only C/EBP distribution;
we utilized mCherry-NF-1 to mark the array as it binds
this structure independently of glucocorticoid (50). In the
absence of glucocorticoids, C/EBP does not localize at the
array (Fig. 9 B, upper). Only after dexamethasone addition
is a clear colocalization of C/EBP and NF-1 visualized at the
array (Fig. 9 B, lower). As GR is expressed endogenously by
these cells, this finding suggests that C/EBP recruitment to
the array is indeed GR-dependent.
In silico, mutations of residues in C/EBPa forming the
interface with GR were predicted to disrupt the GR-C/
EBP interaction. We therefore tested the effects of these mu-
tations by introducing them into fluorescently tagged C/EBP
and analyzing the subcellular distribution of these proteins
after GR activation in living cells (Fig. 9 C). Examination
of 3617 cells transfected with C/EBP mutants revealed
that L315D, I341D, and L317D mutants are able to bind
to the MMTV array, suggesting that these mutations do
not severely affect GR-C/EBP complex formation. Never-
theless, the L317D mutant appeared to lose the ability
to bind to heterochromatin, and its nuclear distributions
appeared more homogenous. Only after the introduction
of both L317D and L335D mutations did we fail to detect
the strong colocalization between C/EBP and GR at the
array, suggesting a lack of interaction between these pro-
teins (Fig. 9 C, last column). The L317DþL335D mutant
additionally presented a very homogenous intranuclear
distribution, an absence of heterochromatin binding, and
even a small population of molecules in the cytoplasmic
compartment.DISCUSSION
Chromatin-remodeling complexes play an important role in
transcriptional regulation by changing the access of pro-
teins to DNA within the context of chromatin (62). Thus,
it is essential to understand the mechanism of action of these
complexes. Determining how individual subunits interact
with one another contributes to knowledge of the mode
of action of the SWI/SNF complex. Understanding how
the structures interact within the SWI/SNF and how they
interact with other transcription factors helps us to under-
stand the steric limits imposed by structure, which in turn
informs on the functional consequences of manipulations
of the remodeling system. This computational work, as
well as previous experimental results (17,20), supports the
premise that multiple subunits of the SWI/SNF complex
are involved in recruitment of the GR. GR lacking the
LBD can interact with BAF60a and BAF57 but not with
BGR1, BAF170, or BAF155. BAF250 also interacts with
GR LBD in pull-down experiments via the BAF250 C-ter-
minus (17), suggesting that there are at least three SWI/
SNF components with which GR can associate. Our results
suggest that the BAF250 C-terminus can indeed interact
with GR through its LBD but not through its DBD.
TABLE 3 Interface analysis of GR DBD-C/EBPa complexes
No. of Residues (Nres)
Surface Area (A˚2)
Interface
Area (A˚2)
No. of Hydrogen
Bonds (NHB)
No. of Salt
Bridges (NSB)Interface (%) Total (%)
Model 1 (BES 16.64)
Target 1 (GR DBD) 16 (10.3) 156 (100) 11,006
Target 2 (C/EBP) 17 (14.2) 120 (100) 11,774
Complex 1059.6 4 6
Model 2 (BES 27.16)
Target 1 (GR DBD) 13 (8.1) 160 (100) 11,761
Target 2 (C/EBP) 13 (10.8) 120 (100) 11,690
Complex 739.9 2 5
The number of interface residues for both monomers and complexes are shown together with their percentage.
Modeling of GR with SWI/SNF and C/EBP 1235BAF57 conversely requires the DBD to bind to GR. We
could not predict the interaction between the BAF60a N-ter-
minus and GR DBD, since modeling did not produce a high-
quality structure for the BAF60a N-terminus. The sequence
identity was <30%. The accuracy of the homology model
is limited to the sequence identity between target and
templates and declines with decreasing sequence identity.
Above 50% sequence identity, generally, reliable models
are generated. On the other hand, a sequence identity
<30% can produce misfolded protein models. Fortunately,
we could model the BAF60a C-terminus and show that
GR does not bind to the C-terminal region of BAF60a as
suggested experimentally. The fact that GR can interact
with multiple SWI/SNF subunits through its LBD or DBD
suggests the possibility of redundancy and compensation.
Thus, a mutation in one SWI/SNF component that abolished
the interaction with GR would not bring about a total loss
of interaction, since the other partners could compensate.
Similarly, a mutation in the LBD or DBD of GR thatTABLE 4 Effects of mutations on C/EBP dimerization and GR
binding
Target 1 PDB ID Target 2 PDB ID
BES
(Wild-Type) Mutation
BES
(Mutant)
C/EBP 1NWQ C/EBP 1NWQ 88.91 L315D 56.86
L317D 43.78
L335D 83.29
I341D 88.39
L317Dþ
L335D
42.72
GR 3G9M C/EBP 1NWQ 16.64
(model 1)
L315D 10.55
L317D 21.45
L335D 11.4
I341D 16.24
L317Dþ
L335D
41.24
GR 1GLU C/EBP 1NWQ 27.16
(model 2)
L315D 25.4
L317D 59.73
L335D 23.58
I341D 27.1
L317Dþ
L335D
72.40affected the interaction with SWI/SNF subunits would not
lead to complete loss of interaction. Multiple interactions
may also enhance the stability of the complex. However,
these interactions are not necessarily equally important.
GR may interact with multiple SWI/SNF complex compo-
nents, but which one or ones are used might depend on
the context and conformation of the GR at a particular bind-
ing site. Thus, changes in one protein could be predicted to
severely affect remodeling and gene expression if that pro-
tein is fairly unique to a location regarding a GR interaction.
Studies suggest that the GR mutant R488Q, with impaired
ability to bind the N-terminal BAF60a, exhibited reduced
chromatin-remodeling activity. Similarly, the GR1-556
mutant, lacking the entire LBD, shows reduced activity of
chromatin remodeling (20). Taken together, these results
suggest that GR DBD interaction with the BAF60a N-termi-
nus or GR LBD interaction with the BRG1 complex plays
an important role in GR-mediated chromatin remodeling.
We also predicted the binary complexes of SWI/SNF sub-
units and constructed models for the multiprotein complex
based on these binary interactions. The models presented
here not only allow us to identify the interacting pairs but
also help us understand how core SWI/SNF subunits interact
with each other and with variant subunits to form the remod-
eling complex. Structural data enable us to predict how the
presence or absence of a domain or a conformational change
within it affects the complex. It allows us to identify the
bridging molecules, like BAF60a, that are responsible for
mediating interactions between different molecules. This
is important because the absence of these molecules or a
mutation at the interface will have profound effects on com-
plex assembly and/or stability. However, we should keep
in mind that the suggested models for the multiprotein
complexes do not represent the entire complex. The vast ma-
jority of the SWI/SNF components do not have crystal struc-
tures in the PDB. Thus, we performed modeling to obtain
the structural data. The quality and accuracy of a homology
model are directly linked with the presence of a high-reso-
lution experimental protein structure as a template and
the sequence identity between the template and target pro-
tein (63,64). In this study, we only used the high-qualityBiophysical Journal 109(6) 1227–1239
FIGURE 8 Residues that are mutated in silico.
Residues that are located at (L315 (purple) and
L317 (yellow)) and away from the interface
(L335 (green) and I341 (light green)) are mutated
in models 1 (A) and 2 (B). To see this figure in co-
lor, go online.
1236 Muratcioglu et al.structural models in our predictions, but models may none-
theless miss some domains that could perhaps stabilize the
complex through additional contacts or destabilize it due
to steric hindrance.
In addition to the chromatin remodelers, GR has been
shown to interact directly with other transcription factors
and alter their function. C/EBP is one such factor (32,65).
Predictions suggest that GR can interact with bZip domains
of C/EBPa homodimer either as a monomer or as a dimer of
the DBD. They further indicate that C/EBP can bind DNA
while interacting with GR. Similarly, GR can bind DNA
while interacting with C/EBP according to the first model.Biophysical Journal 109(6) 1227–1239The first model also suggests that GR-C/EBP interaction
might play a role in long-distance DNA looping between re-
gions where GR and C/EBP bind separately. Similar cases
have been suggested with other factors, such as CTCF,
GATA, and nuclear hormone receptors (66–69). In the
second model, the GR-C/EBP interface overlaps with the
DNA-binding region of GR. Thus, GR cannot interact
with DNA and C/EBP simultaneously in this case. The res-
idues predicted to be structurally important for GR binding
were confirmed by computational mutagenesis. In silico
analysis showed that amino acid variations in C/EBP affect
GR-C/EBP interaction. Our computational results show thatFIGURE 9 In vivo analysis of GR-C/EBP inter-
actions. (A) The 3617 cells (transfected with
pEGFP-C/EBPa and pmCherry-GR) were incu-
bated with ethanol vehicle (Veh) or 100 nM
dexamethasone (Dex). For each cell (n ¼ 67), the
brightness (ε) was calculated as previously
described (52). The figure shows the fold increase
of GR nuclear brightness ε relative to the control
(monomeric GR). A relative brightness of ~2 indi-
cates that most of the molecules are in dimeric
form. *Mean 5 SE, p < 0.05 (Student’s t-test).
(B and C) Representative confocal images of
3617 cells transiently expressing both GFP-C/
EBP and mCherry-NF-1 (B) or both mCherry-GR
and GFP-C/EBP (wild-type (wt) or the indicated
mutations) (C). Scale bar, 5 mm. To see this figure
in color, go online.
Modeling of GR with SWI/SNF and C/EBP 1237single L315D and L317D and double L317DþL335D muta-
tions have a significant impact on GR binding. As expected,
these mutations affected the dimer interaction of C/EBP
bZip domains, as they are located at the dimer interface.
However, they did not disrupt the self-dimerization as they
disrupted the interactions, they just weakened it. These re-
sults imply that these residues have important roles in GR
binding. However, one should keep in mind that in silico
tools are still limited and that their reliability seems to
differ significantly between the various algorithms, so re-
sults often require experimental validation. Accordingly,
studies using a variety of techniques support the predictions
made for SWI/SNF remodeler subunits, and GR interaction
with C/EBP has also been experimentally demonstrated
(32,33). Notable methodological improvements in the pro-
vision of structural information for proteins with inherently
disordered conformation-sensitive folding (70,71) offer
promise for increased reliability of predictions.
In this study, GR was predicted to interact with C/EBP
both as a monomeric and dimeric DBD, and our N&B
data suggested that within the cell, GR took the dimeric
form. It is not clear whether this preference is absolute or
a cell-type-specific phenomenon since other cell types
were not tested. However, in five cell lines tested to date
using the N&B approach, activated nuclear GR has been
dimeric independently of the presumed alternative tran-
scription factor milieu expressed by these different cell
types (52,59). Curiously, despite the strong structural pre-
dictions, when the effects of C/EBP mutations were tested
in vivo, results showed that only the double C/EBP mutant
L317DþL335D failed to be recruited to the MMTV array
in a GR-dependent manner. These data suggest that only
the double mutation severely impaired GR and C/EBP inter-
actions. However, it is noteworthy that the in vivo experi-
ment cannot technically discriminate between a loss of
interaction between GR and C/EBP and the loss of dynamic
assisted loading of C/EBP at a glucocorticoid responsive
unit (29,72).
Overall, computational predictions can be extremely use-
ful as a starting point to interrogate the functional con-
straints that structure imposes on biological molecules. In
addition to computing the likely interfaces involved in
protein-protein interactions, and building interactome
maps (73), such models can also potentially inform on the
downstream effects of pharmacological and experimental
manipulations that produce conformational changes in pro-
teins. Here, we used in silico tools to narrow down potential
target residues for experimental confirmation of the pre-
dicted GR-C/EBP interface. As structural predictive algo-
rithms continue to improve in line with advances in
in vivo experimental technology, it is likely that computa-
tion will play an increasing role in the development and
testing of biological hypotheses relating to the function of
a variety of proteins. Such predictive power will be impor-
tant for the development of novel therapeutic strategiesthat alter specific modalities of protein function to maximize
clinical efficacy while minimizing side effects.SUPPORTING MATERIAL
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